Parkinson’s disrupts key brain connections, PET scan study finds
People with Parkinson’s disease exhibit an interplay between the loss of dopamine-producing neurons and overall nerve…
Andrea Lobo is a Science writer at BioNews. She holds a Biology degree and a PhD in Cell Biology/Neurosciences from the University of Coimbra-Portugal, where she studied stroke biology. She was a postdoctoral and senior researcher at the Institute for Research and Innovation in Health in Porto, in drug addiction, studying neuronal plasticity induced by amphetamines. As a research scientist for 19 years, Andrea participated in academic projects in multiple research fields, from stroke, gene regulation, cancer, and rare diseases. She authored multiple research papers in peer-reviewed journals. She shifted towards a career in science writing and communication in 2022.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
People with Parkinson’s disease exhibit an interplay between the loss of dopamine-producing neurons and overall nerve…
The Parkinson’s Foundation has published a new journal article outlining a practical pathway for making hospital care more age friendly…
Cure Parkinson’s and France Parkinson have joined forces to launch a new international initiative, the Global Alliance for…
Early treatment with the investigational small molecule golexanolone improved motor and cognitive function and eased signs of fatigue, anxiety, and…
Vincere Biosciences won a $5 million grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) to…
The American Parkinson Disease Association (APDA) has announced three recipients of its inaugural Bridge Funding…
Texas voters a a $3 billion state investment to support research into brain diseases such as Parkinson’s disease, a…
In people with early Parkinson’s disease, buntanetap slowed cognitive decline, with the biggest gains…
A $5 million grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) will help Booster Therapeutics develop…
Alector said it is advancing the development of AL050, an enzyme replacement therapy for Parkinson’s disease, with an…
Get regular updates to your inbox.